# ALX Oncology Limited

ALX Oncology Limited is an other based in Burlingame, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Burlingame, United States
- **Region:** North America
- **Address:** 323 Allerton Avenue, South San Francisco, CA 94080, United States
- **Assets under management:** Undisclosed
- **Website:** alxoncology.com

## Regulatory record

- **Reports private funds:** No

## About

We’re dedicated to expanding the possibilities for patients by developing novel approaches to optimize current and future standards of care.

## Sectors

- Biotech
- Oncology
- Immuno-Oncology

## Questions

### Who leads ALX Oncology?

ALX Oncology's leadership team is composed of experienced drug developers; specific named executives are not captured in available sources. The company is publicly traded (NASDAQ: ALXO) and discloses management in SEC filings (per SEC, 2024).

### What is evorpacept and how does it differ from other CD47 inhibitors?

Evorpacept is ALX Oncology's lead therapeutic candidate, a high-affinity SIRPα-Fc fusion protein that blocks the CD47 'don't eat me' signal on cancer cells. It is engineered to reduce the anemia commonly associated with earlier CD47 antibodies, such as those from Forty Seven (per ALX Oncology, 2025).

### What clinical stages is evorpacept in?

As of 2025, evorpacept is in Phase 2 and Phase 1/2 clinical trials across multiple indications, including B-cell non-Hodgkin lymphoma (NCT05894174), head and neck squamous cell carcinoma, and acute myeloid leukemia (per clinicaltrials.gov, 2025). The firm has not yet received FDA approval for any candidate.

### Does ALX Oncology rely solely on internal capital or seek partnerships?

ALX Oncology has funded its operations through public equity offerings and, in December 2023, announced a strategic collaboration with Coherus BioSciences to evaluate evorpacept in combination with toripalimab (per SEC, 2023). The firm partners with larger biopharmas for co-development.

## Related profiles

- [JPW Industries](https://altss.com/profile/jpw-industries-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/alx-oncology-limited

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology